“A Clinical and Comparative Study of Manadya Gudika & Shobhanjanadi Kwath in the management of Yakritpleeha Vikar.â€
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- 1. Mankanda
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients in the age group of 18 to 60 years will be taken.
- •The patients of "Yakritapleeha Vikar" will be selected on the basis of clinical preferences described in Ayurveda:- Anemia (Raktalpta) Loss of appetite ( Khudhanash) fever ( Mridu Jwar) anorexia (Aruchi) Vomiting (Vaman) Enlarge liver and spleen ( Yakrita and Pleeha vridhi) Reference.
- •Charak chikitsa 13/ 37-38.
排除标准
- ••Liver abscess ( Pyogenic and Amoebic ) •Cirrhosis of liver •liver failure •Ischemic heart disease •Chronic renal failure •Nephrotic syndrome •Sickle cell anaemia •Severe HTN [ B.P. more than 150/100 ] •Hepatocellular or any other carcinoma •Portal hypertension •Tuberculosis •Ascites •HIV.
- •Positive •Type 1 DM •Cancer •Sexual Transmitted Disease.
结局指标
主要结局
1. Mankanda
时间窗: 90 Days
10. Saindhav
时间窗: 90 Days
11. Vid Lavan
时间窗: 90 Days
14. Gomutra
时间窗: 90 Days
Manadya Gudika
时间窗: 90 Days
13. Yava Kshar
时间窗: 90 Days
Reference:- Chakradatta yakritapleeha rogadhikar chapter 38/17
时间窗: 90 Days
(English translation by Dr. Prabhakar Rao )
时间窗: 90 Days
2. Apamarg
时间窗: 90 Days
3. Guduchi
时间窗: 90 Days
5. Shalparni
时间窗: 90 Days
9. Talpushapa
时间窗: 90 Days
12. Sauvarchal Lavan
时间窗: 90 Days
15. Madhu
时间窗: 90 Days
Drug Form :- Gutika
时间窗: 90 Days
Dose :- 500mg tab / Morning and evening time after meal
时间窗: 90 Days
Anupan :- Ushnodaka (Lukewarm Water)
时间窗: 90 Days
Total no. of Content drugs:- 15 drugs
时间窗: 90 Days
4. Vasa
时间窗: 90 Days
7. Chitrak
时间窗: 90 Days
8. Shunthi
时间窗: 90 Days
6. Pipali
时间窗: 90 Days
次要结局
- Shobhanjanadi Kwath(Reference:- Chakradatta yakritapleeha rogadhikar chapter 38/08 (English translation))
